World-class cyclists on erythropoietin

Affiliations

Comment

Jules A A C Heuberger et al. Br J Clin Pharmacol. 2014 Mar.

. 2014 Mar;77(3):582.

doi: 10.1111/bcp.12186.

No abstract available

Comment on

Erythropoietin doping in cycling: lack of evidence for efficacy and a negative risk-benefit.
Heuberger JA, Cohen Tervaert JM, Schepers FM, Vliegenthart AD, Rotmans JI, Daniels JM, Burggraaf J, Cohen AF. Heuberger JA, et al. Br J Clin Pharmacol. 2013 Jun;75(6):1406-21. doi: 10.1111/bcp.12034. Br J Clin Pharmacol. 2013. PMID: 23216370 Free PMC article.
Little soldiers in their cardboard cells.
van Breda E, Benders J, Kuipers H. van Breda E, et al. Br J Clin Pharmacol. 2014 Mar;77(3):580-1. doi: 10.1111/bcp.12187. Br J Clin Pharmacol. 2014. PMID: 23772979 Free PMC article. No abstract available.

1. van Breda E, Benders J, Kuipers H. Little soldiers in their cardboard cells. Br J Clin Pharmacol. 2014;77:580–581. - PMC - PubMed
1. Lage JM, Panizo C, Masdeu J, Rocha E. Cyclist's doping associated with cerebral sinus thrombosis. Neurology. 2002;58:665. - PubMed
1. Lucia A, Hoyos J, Perez M, Santalla A, Earnest CP, Chicharro JL. Which laboratory variable is related with time trial performance time in the Tour de France? Br J Sports Med. 2004;38:636–640. - PMC - PubMed
1. Padilla S, Mujika I, Cuesta G, Goiriena JJ. Level ground and uphill cycling ability in professional road cycling. Med Sci Sports Exerc. 1999;31:878–885. - PubMed
1. Padilla S, Mujika I, Angulo F, Goiriena JJ. Scientific approach to the 1-h cycling world record: a case study. J Appl Physiol. 2000;89:1522–1527. - PubMed